Bausch Health Companies Inc.
N/MPrice / tangible book
Market cap
$2.46B
Tangible equity
-$16.47B
Price / tangible book
N/M
Price / book
N/M
Return on equity
-28.3%
Return on assets
0.6%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: BHC stock price at premium vs HBAN $6.57 current versus $5.15 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HBAN's multiple
Implied fair value · at BHC's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Multiple discount
Multiple discount
Profitability lag
Asset efficiency lag
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: BHC FY 2025 (ended Dec 31, 2025) · HBAN FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / tangible book
Market cap
$2.46B
Tangible equity
-$16.47B
Price / tangible book
N/M
Price / book
N/M
Return on equity
-28.3%
Return on assets
0.6%
Efficiency ratio
—
Price / tangible book
Market cap
$34.56B
Tangible equity
$18.20B
Price / tangible book
1.90x
Price / book
1.42x
Return on equity
9.1%
Return on assets
1.0%
Efficiency ratio
40.2%
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Bausch Health Companies Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Huntington Bancshares Incorporated · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-37.98x
0.76x
Net debt / EBITDA
Leverage against operating earnings
8.15x
—
Cash and equivalents
Liquid reserves on the balance sheet
$1.31B
—
Total debt
Interest-bearing obligations outstanding
$21.04B
$18.48B
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AbbVie Inc.
BHC vs ABBV
Organon & Co.
BHC vs OGN
TEVA PHARMACEUTICAL INDUSTRIES LTD
BHC vs TEVA
SUPERNUS PHARMACEUTICALS, INC.
BHC vs SUPN
ANI PHARMACEUTICALS INC
BHC vs ANIP
JPMorgan Chase & Co.
BHC vs JPM
Bank of America Corporation
BHC vs BAC
Wells Fargo & Company
BHC vs WFC
Citigroup Inc.
BHC vs C
PNC FINANCIAL SERVICES GROUP, INC.
BHC vs PNC
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.